I will do an easy one first. MND was very light touch as there is a webinar next week (Tuesday) from the ladies running the trial.
My take outs - We now have 5 in the trial (one more since last update which was not so long ago) - we have 6 required for the first cohort (so at 5 out of 6 now) - first cohort hoped to be fully recruited and though the 28 days by christmas (but data will likely take longer - note also it will be christmas) - so far everything is going well and no adverse events - second cohort of 6 will have a dose escalation - then there will be a cohort 3 and 4 (6 in each) - treatment for those on trial will be available to continue should they wish - The board seems VERY up beat on MND (IMO)
I am really looking forward to the webinar.
I am working on a dogs post - there is a load to share. hope it won't be long, just doing some detail checking now.
adreamer
if i missed anything or you have a Q, throw it up on this and will try and answer.
PAA Price at posting:
8.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)